CREJUV BIO is a biopharmaceutical R&D company for the B2B tech licensing.
We license out technologies, not products, for the Aesthetic Botulinum Toxin.
It comes with ready-to-use liquid form in pre-filled syringe.
We will provide an optimized and patented botulinum toxin formulation for aesthetic treatment.
We were approved for the Start-Up Visa Program from Government of Canada in 2019 and founded the company in BC Canada in April 2020.
11Built CREJUV Team
04Applied Canada Start-Up Visa Program
10Approved SUV Program from Canada
12Visited to Prepare CL2 Lab. in Vancouver BC
04Established CREJUV BIO Inc. in BC Canada
(#738986132BC0001)
09Start Fundraising for Final 10M USD
01Formulation Patent Pending
(#63133889)